COVID-19 case rates among incarcerated individuals are five times higher compared to the general public.
Yale University received a supplement to support a study to increase the reach, access, uptake, and impact of COVID-19 testing and to mitigate the impact of COVID-19 among incarcerated people and corrections staff. The initiative’s multidisciplinary team will be working with jails and prisons across Florida, Rhode Island, Minnesota, and Washington to address the urgent need for the development and implementation of long-term COVID-19 testing and prevention strategies. The long-term goal is to mitigate the impact of COVID-19 in correctional facilities while considering the ethical issues that must be addressed to optimize implementation and effectiveness.
This project was provided as a supplement to the National Institute on Drug Abuse (NIDA) from the NIH Rapid Acceleration of Diagnostics Underserved Populations (RADx-UP) program.
Study Settings: Jails/Prisons
Study Locations: Florida, Minnesota, Rhode Island, Washington
Emily Wang, MD, MAS
Yale University School of Medicine
Lauren Brinkley-Rubinstein, PhD
University of North Carolina at Chapel Hill
Rosemarie Martin, PhD
• Identify ethical concerns and potential solutions for COVID-19 testing and vaccine strategies in correctional facilities using a community-engaged strategy
• Characterize incidence of COVID-19, disease progression, and related-outcomes and effectiveness of testing and contact tracing (among staff and people who are incarcerated) in correctional facilities
• Mitigate the impact of COVID-19 in correctional facilities while considering the ethical issues that must be addressed to optimize implementation and effectiveness
COVID-19 Testing, RADX-UP Supplement